National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 67358-67359 [2020-23365]
Download as PDF
<![CDATA[
67358
Federal Register / Vol. 85, No. 205 / Thursday, October 22, 2020 / Notices
database that is maintained by the
Committee Management Secretariat of
the General Services Administration.
The website address for this database is
https://www.facadatabase.gov/.
L609A, Washington, DC 20024; (202)
795–7622 or PACHA@hhs.gov.
Additional information can be obtained
by accessing the Council’s page on the
HIV.gov site at www.hiv.gov/pacha.
Maria G. Button,
Director, Executive Secretariat.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2020–23363 Filed 10–21–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice of a virtual meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service is hereby giving notice that the
Presidential Advisory Council on HIV/
AIDS (PACHA or the Council) will be
holding the 69th full Council meeting
utilizing virtual technology. PACHA
members will be discussing HIV, the
Ending the HIV Epidemic: A Plan for
America (EHE) initiative, and the novel
coronavirus (COVID–19). The meeting
will be open to the public; a public
comment session will be held during
the meeting. Pre-registration is required
to provide public comment. To preregister to attend or to provide public
comment, please send an email to
PACHA@hhs.gov and include your
name, organization, and title by close of
business Friday November 20, 2020. If
you decide you would like to provide
public comment but do not pre-register,
you may submit your written statement
by emailing PACHA@hhs.gov by close of
business Thursday, December 10, 2020.
The meeting agenda will be posted on
the PACHA page on HIV.gov at https://
www.hiv.gov/ federal-response/pacha/
about-pacha prior to the meeting.
DATES: The meeting will be held on
Wednesday, December 2 and Thursday,
December 3, 2020, from approximately
1:00 p.m. to 5:00 p.m. (ET) on both days.
This meeting will be conducted
utilizing virtual technology.
ADDRESSES: Instructions on attending
this meeting virtually will be posted one
week prior to the meeting at: https://
www.hiv.gov/federal-response/pacha/
about-pacha.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, MPA, Public Health
Analyst, Presidential Advisory Council
on HIV/AIDS, 330 C Street SW, Room
SUMMARY:
VerDate Sep<11>2014
17:35 Oct 21, 2020
Jkt 253001
PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996 and is currently operating
under the authority given in Executive
Order 13889, dated September 27, 2019.
The Council was established to provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective
prevention and care of HIV infection
and AIDS. The functions of the Council
are solely advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House.
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Engineering Immunity to
HIV–1 Through Next Generation Vaccines
(R61/R33 Clinical Trial Not Allowed).
Date: November 20, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John C. Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 6701 Rockledge Drive,
Room 1206, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 16, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23369 Filed 10–21–20; 8:45 am]
BILLING CODE 4140–01–P
Dated: October 15, 2020.
B. Kaye Hayes,
Principal Deputy Director, Office of Infectious
Disease and HIV/AIDS Policy, Executive
Director, Presidential Advisory Council on
HIV/AIDS, Office of the Assistant Secretary
for Health, Department of Health and Human
Services.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–23397 Filed 10–21–20; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rational Design of Vaccines
Against Hepatitis C Virus (U19 Clinical Trial
Not Allowed).
Date: November 18–19, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
E:\FR\FM\22OCN1.SGM
22OCN1
Federal Register / Vol. 85, No. 205 / Thursday, October 22, 2020 / Notices
Health, 5601 Fishers Lane, Room 3E72,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3E72, Bethesda, MD
20892–9834, (240) 669–5023, fdesilva@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 16, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23365 Filed 10–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Toxicology Program Board of
Scientific Counselors; Announcement
of Meeting; Request for Comments
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice announces the
next meeting of the National Toxicology
Program (NTP) Board of Scientific
Counselors (BSC). The BSC, a federally
chartered, external advisory group
composed of scientists from the public
and private sectors, will review and
provide advice on programmatic
activities. This meeting is by webcast
only and is open to the public. Written
comments will be accepted and
registration is required to present oral
comments. Information about the
meeting and registration are available at
https://ntp.niehs.nih.gov/go/165.
DATES:
Meeting: Scheduled for December 3,
2020, at 12:30 p.m. to adjournment on
December 4, 2020, at approximately
5:00 p.m. Eastern Standard Time (EST).
Written Public Comment
Submissions: Deadline is November 20,
2020.
Registration for Oral Comments:
Deadline is November 20, 2020.
ADDRESSES:
Meeting web page: The preliminary
agenda, registration, and other meeting
materials are available at https://
ntp.niehs.nih.gov/go/165.
Webcast: The URL for viewing the
meeting webcast will be provided on the
meeting web page.
SUMMARY:
VerDate Sep<11>2014
17:35 Oct 21, 2020
Jkt 253001
Dr.
Mary Wolfe, Designated Federal Official
for the BSC, Office of Liaison, Policy
and Review, Division of NTP, NIEHS,
P.O. Box 12233, K2–03, Research
Triangle Park, NC 27709. Phone: 984–
287–3209, Fax: 301–451–5759, Email:
wolfe@niehs.nih.gov. Hand Deliver/
Courier address: 530 Davis Drive, Room
K2130, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION: The BSC
will provide input to the NTP on
programmatic activities and issues. The
preliminary agenda topics include an
update on the status of the Division of
the National Toxicology Program
(DNTP)’s strategic realignment, an
introduction to DNTP’s draft strategic
plan, and presentations from two
program areas. The preliminary agenda,
roster of BSC members, background
materials, public comments, and any
additional information, when available,
will be posted on the BSC meeting web
page (https://ntp.niehs.nih.gov/go/165)
or may be requested in hardcopy from
the Designated Federal Official for the
BSC. Following the meeting, summary
minutes will be prepared and made
available on the BSC meeting web page.
Meeting Attendance Registration: The
meeting is open to the public with time
scheduled for oral public comments.
Registration is not required to view the
webcast; the URL for the webcast is
provided on the BSC meeting web page
(https://ntp.niehs.nih.gov/go/165). TTY
users should contact the Federal TTY
Relay Service at 800–877–8339.
Requests should be made at least five
business days in advance of the event.
Written Public Comments: NTP
invites written public comments.
Guidelines for public comments are
available at https://ntp.niehs.nih.gov/
ntp/about_ntp/guidelines_public_
comments_508.pdf.
The deadline for submission of
written comments is November 20,
2020. Written public comments should
be submitted through the meeting web
page. Persons submitting written
comments should include name,
affiliation, mailing address, phone,
email, and sponsoring organization (if
any). Written comments received in
response to this notice will be posted on
the NTP web page, and the submitter
will be identified by name, affiliation,
and sponsoring organization (if any).
Oral Public Comment Registration:
The agenda allows for four formal
public comment periods—two comment
periods on Day 1 for DNTP’s strategic
realignment and draft strategic plan and
two comment periods on Day 2 for the
two program areas (up to 3 commenters,
up to 5 minutes per speaker, per topic).
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
67359
Persons wishing to make an oral
comment are required to register online
at https://ntp.niehs.nih.gov/go/165 by
November 20, 2020. Oral comments will
be received only during the formal
comment periods indicated on the
preliminary agenda. Oral comments will
only be by teleconference line. The
access number for the teleconference
line will be provided to registrants by
email prior to the meeting. Registration
is on a first-come, first-served basis.
Each organization is allowed one time
slot per topic. After the maximum
number of speakers per comment period
is exceeded, individuals registered to
provide oral comment will be placed on
a wait list and notified should an
opening become available. Commenters
will be notified approximately one week
before the meeting about the actual time
allotted per speaker.
If possible, oral public commenters
should send a copy of their slides and/
or statement or talking points to NTPMeetings@icf.com by November 20,
2020.
Meeting Materials: The preliminary
meeting agenda is available on the
meeting web page (https://
ntp.niehs.nih.gov/go/165) and will be
updated one week before the meeting.
Individuals are encouraged to access the
meeting web page to stay abreast of the
most current information regarding the
meeting.
Background Information on the BSC:
The BSC is a technical advisory body
comprised of scientists from the public
and private sectors that provides
primary scientific oversight to the NTP.
Specifically, the BSC advises the NTP
on matters of scientific program content,
both present and future, and conducts
periodic review of the program for the
purpose of determining and advising on
the scientific merit of its activities and
their overall scientific quality. Its
members are selected from recognized
authorities knowledgeable in fields such
as toxicology, pharmacology, pathology,
epidemiology, risk assessment,
carcinogenesis, mutagenesis, cellular
biology, computational toxicology,
neurotoxicology, genetic toxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
The BSC usually meets periodically.
The authority for the BSC is provided by
42 U.S.C. 217a, section 222 of the Public
Health Service Act (PHS), as amended.
The BSC is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C.
app.), which sets forth standards for the
formation and use of advisory
committees.
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 85, Number 205 (Thursday, October 22, 2020)]
[Notices]
[Pages 67358-67359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23365]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Rational Design of Vaccines Against
Hepatitis C Virus (U19 Clinical Trial Not Allowed).
Date: November 18-19, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of
[[Page 67359]]
Health, 5601 Fishers Lane, Room 3E72, Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Frank S. De Silva, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E72,
Bethesda, MD 20892-9834, (240) 669-5023, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 16, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-23365 Filed 10-21-20; 8:45 am]
BILLING CODE 4140-01-P
